IDXG - INTERPACE BIOSCIENCES, INC.
4.09
2.590 63.325%
Share volume: 0
Last Updated: 03-10-2021
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.50
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-08-2024 | 05-08-2025 | 08-07-2025 | 11-12-2025 | |
| Total revenue | 12.295 M | 11.515 M | 9.232 M | 8.756 M | |
| Cost of revenue | 4.789 M | 4.145 M | 3.956 M | 3.317 M | |
| Gross profit | 7.506 M | 7.370 M | 5.276 M | 5.439 M | |
| -1.81% | -28.41% | 3.09% | |||
| Operating expenses | 2.737 M | 2.727 M | 2.834 M | 2.207 M | |
| Selling general and admin | 2.538 M | 2.550 M | 2.661 M | 2.057 M | |
| Research and development | 199.000 K | 177.000 K | 173.000 K | 150.000 K | |
| Total expenses | 5.601 M | 5.541 M | 5.744 M | 4.294 M | |
| -1.07% | 3.66% | -25.24% | |||
| Operating income | 1.905 M | 1.829 M | -468.000 K | 1.145 M | |
| Ebit | 1.511 M | 1.850 M | -484.000 K | 1.030 M | |
| Pretax income | 1.366 M | 1.772 M | -533.000 K | 1.000 M | |
| 29.72% | -130.08% | -287.62% | |||
| Income tax | 4.000 K | 18.000 K | 0.000 | -11.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.280 M | 1.647 M | -640.000 K | 911.000 K | |
| 28.67% | -138.86% | 242.34% |